Quantitative analysis revealed no significant difference between control subjects and PD patients in terms of either apical dendrites positive for acetylated α-Tubulin (Supplementary Fig. 3r) or co-localization between MAP2 and acetylated α-Tubulin (Mander’s coefficient; Supplementary Fig. 3s). This evidence concerns the gene MAP2 and Parkinson disease.